Circulating Tumor DNA (ctDNA) in Early Breast Cancer | Dana-Farber Cancer Institute

0 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Stefania Morganti, MD, a researcher in the Breast Oncology Program, discusses circulating tumor DNA (ctDNA) and how it is used to detect minimal residual disease in patients with early stage breast cancer.

For more information about the Breast Oncology Program, visit https://www.dana-farber.org/cancer-care/treatment/breast-oncology
Category
Oncology
Be the first to comment

Up Next